1-(4-Chloro-2-fluoro-6-hydroxyphenyl)ethanone, 95.0%, 100mg

2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-, (2E)-, 50mg

Quinidine sulphate dihydrate, min. 99%, 10 g, glass packaging

2-Nitrobenzyl Alcohol>98.0%(GC)25g

(Z)-4-((tert-butyldimethylsilyl)oxy)but-2-en-1-ol, 95%, 1g

(Phenylsulfonyl)acetonitrile, 98.0%, 5g

N-propylcyclopentanamine hydrochloride, 95.0%, 5g

2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 500mg

1,2,4,5-Tetrahydro-benzo[e][1,4]diazepin-3-one, 97.0%, 5g

methyl 1-(2-chloroacetyl)-2-hydroxy-1H-indole-6-carboxylate, 97%, 100mg

Potassium 1,3-dioxoisoindolin-2-ide, 98.0%, 1kg

4-(Cyanomethyl)benzoic acid, 97.0%, 25g

Phenylethylisocyanide, 95.0%, 5g